LU77585A1 - - Google Patents

Info

Publication number
LU77585A1
LU77585A1 LU77585A LU77585A LU77585A1 LU 77585 A1 LU77585 A1 LU 77585A1 LU 77585 A LU77585 A LU 77585A LU 77585 A LU77585 A LU 77585A LU 77585 A1 LU77585 A1 LU 77585A1
Authority
LU
Luxembourg
Application number
LU77585A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU77585A1 publication Critical patent/LU77585A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
LU77585A 1976-06-21 1977-06-20 LU77585A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25577/76A GB1575009A (en) 1976-06-21 1976-06-21 6,7-benzomorphan derivatives

Publications (1)

Publication Number Publication Date
LU77585A1 true LU77585A1 (en:Method) 1977-09-29

Family

ID=10229936

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77585A LU77585A1 (en:Method) 1976-06-21 1977-06-20

Country Status (11)

Country Link
US (2) US4234591A (en:Method)
JP (1) JPS52156869A (en:Method)
BE (1) BE855938A (en:Method)
CH (1) CH634562A5 (en:Method)
DE (1) DE2726836A1 (en:Method)
DK (1) DK270077A (en:Method)
FR (1) FR2355830A1 (en:Method)
GB (1) GB1575009A (en:Method)
IE (1) IE44938B1 (en:Method)
LU (1) LU77585A1 (en:Method)
NL (1) NL7706328A (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460298A1 (fr) * 1979-06-28 1981-01-23 Sterling Drug Inc Procede de preparation de 2,6-methano-3-benzazocines
DE19907874A1 (de) * 1999-02-23 2000-08-24 Boehringer Ingelheim Pharma N-(5-Phenyl-tetrahydrofuranyl)methyl- und N-(6-Phenyl-tetrahydropyranyl)methyl substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
TW201431842A (zh) * 2012-11-09 2014-08-16 Purdue Pharma Lp 苯並嗎啡烷類似物及其應用
WO2014118618A1 (en) * 2013-01-31 2014-08-07 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
MA39956A (fr) * 2014-05-06 2015-11-12 Purdue Pharma Lp Analogues du benzomorphane et leur utilisation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (en:Method) * 1958-09-22
NL130089C (en:Method) * 1963-11-07
US3639407A (en) * 1965-05-05 1972-02-01 Geigy Chem Corp Novel 1 2 3 4 5 6-hexahydro-6-phenyl-2 6-methano-3-benzazocines
DE1545827C3 (de) * 1965-06-25 1975-09-11 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 6,7-Benzomorphanen
US3499906A (en) * 1966-05-20 1970-03-10 Merck & Co Inc 5,9-diethyl-2'-hydroxy-2-substituted-6,7-benzomorphans
SE394277B (sv) * 1967-06-07 1977-06-20 Sumitomo Chemical Co Forfarande for framstellning av 6,7-bensomorfanderivat
US3553223A (en) * 1968-01-05 1971-01-05 Hoffmann La Roche Acid catalyzed cyclization of tetrahydropyridines containing an electron withdrawing group on the nitrogen
US3639410A (en) * 1968-07-26 1972-02-01 Sterling Drug Inc 1 2 3 4 5 6 - hexahydro - 8 - substituted-6-alkyl-11-(h or a lkyl) - 26-methano-3-benzazocines
US3511846A (en) * 1968-12-16 1970-05-12 Geigy Chem Corp Process for the preparation of optically active benzazocines
BR6914879D0 (pt) * 1969-01-23 1973-02-08 Merck & Co Inc Processos quimicos
CS166802B2 (en:Method) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
US3932422A (en) * 1974-05-20 1976-01-13 Sterling Drug Inc. 8-Methylene-3-azabicyclo[3.3.1]non-6-en-4-ones
DE2437610A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
US4108857A (en) * 1975-08-18 1978-08-22 Sterling Drug Inc. Imidazolylmethyl methanobenzazocines
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
DK270077A (da) 1977-12-22
GB1575009A (en) 1980-09-17
JPS52156869A (en) 1977-12-27
FR2355830A1 (fr) 1978-01-20
US4288444A (en) 1981-09-08
CH634562A5 (de) 1983-02-15
DE2726836A1 (de) 1977-12-29
FR2355830B1 (en:Method) 1981-04-30
NL7706328A (nl) 1977-12-23
IE44938B1 (en) 1982-05-19
IE44938L (en) 1977-12-21
BE855938A (nl) 1977-12-21
US4234591A (en) 1980-11-18

Similar Documents

Publication Publication Date Title
CS175518B1 (en:Method)
CS177800B1 (en:Method)
CS177973B1 (en:Method)
DD126205A1 (en:Method)
DD126388A5 (en:Method)
BG23464A1 (en:Method)
BG26127A1 (en:Method)
CH595073A5 (en:Method)
CH596965A5 (en:Method)
CH599834A5 (en:Method)
CH601629A5 (en:Method)
CH601738A5 (en:Method)
CH601810A5 (en:Method)
CH601828A5 (en:Method)
CH601846A5 (en:Method)
CH601903A5 (en:Method)
CH602406A5 (en:Method)
CH603972A5 (en:Method)
CH604276A5 (en:Method)
CH604437A5 (en:Method)
CH605329A5 (en:Method)
CH607506A5 (en:Method)
CH609483A5 (en:Method)
CH610840A5 (en:Method)
CH611751A5 (en:Method)